PTO/Sb/08b (06-09)
`Approved for use through 07/31/2009. 0MB 0651-0031
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid
`0MB control number.
`
`Complete if Known
`Aoolication Number
`13/024,727
`February 10, 2011
`Filinq Date
`Simon
`First Named Inventor
`Art Unit
`tbd
`Examiner Name
`tbd
`Attorney Docket Number
`ELEC-34
`
`Substitute for form 1449/PTO
`
`INFORMATION DISCLOSURE
`STATEMENT BY APPLICANT
`
`(Use as many sheets as necessary)
`I 1
`I OF
`I 7
`Sheet
`
`Exami Cite No.
`ner
`lnts
`
`1 .
`
`2.
`
`3.
`
`4.
`
`5.
`
`6.
`
`7.
`
`8.
`
`9.
`
`10.
`
`11 .
`
`12.
`
`13.
`
`14.
`
`15.
`
`16.
`
`17.
`
`Include name of the author (in CAPITAL LETTERS), title of the article (when
`appropriate), title of the item (book, magazine, journal, serial, symposium, catalog,
`etc.), date, pages, volume/issue number(s), publisher, city and/or country where
`published.
`"Patient's Manual. For Vagus Nerve Stimulation with the VNS Therapy™ System. March
`2004". Publication REF 26-0005-6000/1. Cyberonics, Inc., Houston, Texas (Table 1 and
`paqes 16-21 ).
`ABOSCH et al. Biological basis for the surgical treatment of depression. Neurosurg Focus
`25 (1,2008) :E2 (pp. 1-12,001: 10.3171 /FOC/2008/25/7/E2).
`ALBERT, et al. Deep brain stimulation, vagal nerve stimulation and transcranial
`stimulation: An overview of stimulation parameters and neurotransmitter release.
`Neuroscience and Biobehavioral Reviews 33 (2009) 1042-1060.
`AL-MUTAWALY, et al. The Effects of Pulse Configuration on Magnetic Stimulation. Journal
`of Clinical Neurophysioloqy 20(5) :361-370, 2003.
`ANDERSON, et al. Decreasing Procedural Pain Over Time of Left Prefrontal rTMS
`forDepression: Initial Results from the Open-Label Phase of a Multisite Trial (OPT-TMS).
`Brain Stimul. 2009 April 1; 2(2): 88-92.
`ANONYMOUS. Vagus Nerve Stimulation for Treatment-Resistant Depression. TEC
`Assessment Proqram 21 (7,2006).
`ARUL-ANANDAM et al. Induction of Hypomanic Episode With Transcranial Direct Current
`Stimulation. Journal of ECT 26(1,2010): 68-69.
`AZIZ et al. Magnetic Stimulation of Efferent Neural Pathways to the Human Oesophagus.
`Gut 33: S53-S70 (Poster Session F218) (1992).
`AZIZ, Q. et al. Esophageal myoelectric responses to magnetic stimulation of the human
`cortex and the extracranial vagus nerve. Am. J. Physiol. 267 (Gastrointest. Liver Physiol.
`30): G827-G835, 1994.
`BASHAM, et al. Magnetic Stimulation of Neural Tissue: Techniques and System Design.
`pp 293- 352, In: Implantable Neural Prostheses 1, Devices and Applications, D. Zhou and
`E. Greenbaum, eds., New York: Sprinqer (2009).
`BERRIDGE et al. Affective neuroscience of pleasure: reward in humans and animals.
`Psychopharmacology (2008) 199:457-480.
`BLOOD et al. Intensely pleasurable responses to music correlate with activity in brain
`reqions implicated in reward and emotion. PNAS 98 (20,2001): 11818-11823.
`BODKIN et al. Buprenorphine treatment of refractory depression. Journal of Clinical
`Psychopharmacology 15(1, 1995): 49-57.
`BOECKER, et al.The Runner's High: Opioidergic Mechanisms in the Human Brain.
`Cerebral Cortex 18(2008): 2523-2531 .
`BORCKARDT, et al. Reducing Pain and Unpleasantness During Repetitive Transcranial
`Magnetic Stimulation. Journal of ECT 2006; 22:259-264.
`BEJJANI et al. Transient acute depression induced by high-frequency deep-brain
`stimulation. The New Enqland Journal of Medicine 340(19, 1999) 1476-1480.
`BOWTELL et al. Analytic Calculations of the E-Fields Induced by Time-Varying Magnetic
`
`Examiner
`Date
`08/12/2013
`/Catherine Voorheesi
`Si nature
`Considered
`*EXAMINER: Initial if reference considered, whether or not citation is in conformance with MPEP 609. Draw line through citation if not in conformance and
`not considered. Include copy of this form with next communication to applicant.
`1Applicant's unique citation designation number (optional). 2Applicant is to place a check mark here if English language Translation is attached.
`This collection of information is required by CFR 1 .98. The information is required to obtain or retain a benefit by the public which is to file (and by the
`US PTO to process) an application. Confidentiality is governed by 35 U.S.C. 122 and 37 CFR 1.14. This collection is estimated to take 2 hours to
`complete, including gathering, preparing, and submitting the completed application form to the USPTO. Time will vary depending upon the individual case.
`Any comments on the amount of time you require to complete this form and/or suggestions for reducing this burden, should be sent to the Chief
`Information Officer, U.S. Patent and Trademark Office, P.O. Box 1450, Alexandria, VA 22313-1450. DO NOT SEND FEES OR COMPLETED FORMS TO
`THIS ADDRESS. SEND TO: Commissioner for Patents, P.O. Box 1450, Alexandria, VA 22313-1450.
`If you need assistance in completing the form, call 1-800-PTO-9199 (1-800-786-9199) and select option 2.
`
`ALL REFERENCES CONSIDERED EXCEPT WHERE LINED THROUGH. /C.V./
`
`LUMENIS EX1057
`Page 1
`
`

`

`PTO/Sb/08b (06-09)
`Approved for use through 07/31/2009. 0MB 0651-0031
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid
`0MB control number.
`
`Substitute for form 1449/PTO
`
`INFORMATION DISCLOSURE
`STATEMENT BY APPLICANT
`
`(Use as many sheets as necessary)
`I 2
`I OF
`I 7
`Sheet
`
`Complete if Known
`Aoolication Number
`13/024,727
`February 10, 2011
`Filinq Date
`Simon
`First Named Inventor
`Art Unit
`tbd
`Examiner Name
`tbd
`Attorney Docket Number
`ELEC-34
`
`Exami Cite No.
`ner
`lnts
`
`Include name of the author (in CAPITAL LETTERS), title of the article (when
`appropriate), title of the item (book, magazine, journal, serial, symposium, catalog,
`etc.), date, pages, volume/issue number(s), publisher, city and/or country where
`published.
`Fields Generated by Cylindrical Gradient Coils. Magnetic Resonance in Medicine 44:782-
`790 (2000).
`18. BURGDORF et al. The neurobiology of positive emotions. Neuroscience and Biobehavioral
`Reviews 30 (2006): 173-187.
`19. CARBUNARU et al. Toroidal coil models for transcutaneous magnetic stimulation of
`nerves. IEEE Transactions on Biomedical Enaineerina. 48 (No. 4, April 2001 ): 434-441.
`20. CASTLE et al. Autonomic brainstem nuclei are linked to the hippocampus. Neuroscience
`134 (2005) 657-669.
`21. CHAE et al. A review of functional neuroimaging studies of vagus nerve stimulation (VNS).
`Journal of Psychiatric Research 37 (2003) 443-455.
`22. CLARKE et al. Early carbon monoxide intoxication: happy to be poisoned? Emerg Med J
`2005;22:754-755.
`23. COENEN et al. Medial forebrain bundle stimulation as a pathophysiological mechanism for
`hypomania in subthalamic nucleus deep brain stimulation for Parkinson's disease.
`Neurosurgery. 2009 Jun;64(6):1106-14.
`24. DALGLEISH. The emotional brain. Nat Rev Neurosci. 5(7,2004):583-589.
`25. DAVEY. Magnetic Stimulation Coil and Circuit Design. IEEE Transactions on Biomedical
`Enaineerina, Vol. 47 (No. 11, Nov. 2000): 1493-1499.
`26. EKMAN et al. The Duchenne smile: Emotional expression and brain physiology II. Journal
`of Personality and Social Psycholoay. 1990;58:342-353.
`27. DELITTO et al. A Study of Discomfort with Electrical Stimulation. Phys. Ther. 1992;
`72:410-424.
`28. DREVETS et al. Amphetamine-induced dopamine release in human ventralstriatum
`correlates with euphoria. Biol Psychiatry 49(2,2001) :81-96.
`29. ENDICOTT. PMDD criteria. Diagnostic and Statistical Manual of Mental Disorders,
`American Psychiatric Association, 2000.
`30. Engineer et al. Reversing pathological neural activity using targeted plasticity. Nature
`(2011): published online doi:10.1038/nature09656.l.
`31. ANGSTJ. The emerging epidemiology of hypomania and bipolar II disorder. Journal of
`Affective Disorders 50 (1998) 143-151.
`32. ESSELLE et al. Neural stimulation with magnetic fields: Analysis of induced electric fields,
`IEEE T11111 rans. Biomed. Ena., 39 (July 1992), pp_ 693-700.
`FAIERSTEIN et al. Coil Designs for Localized and Efficient Magnetic Stimulation of the
`Nervous System. Ph.D. Dissertation, Department of Biomedical Engineering, Case
`Western Reserve, May, 1999. (UMI Microform Number: 9940153, UMI Company, Ann
`Arbor Ml).
`FAIERSTEIN. Coil Designs for Localized and Efficient Magnetic Stimulation of the Nervous
`System. Ph.D. Dissertation, Department of Biomedical Engineering, Case Western
`Reserve, May, 1999, paae 117 (UMI Microform Number: 9940153, UMI Company, Ann
`I Examiner
`08/12/2013
`iCatherine Voorhees/
`I Date
`I
`I
`I
`Considered
`Sia nature
`*EXAMINER: Initial 1f reference considered, whether or not cItatIon Is In conformance with MPEP 609. Draw line through cItatIon 1f not In conformance and
`not considered. Include copy of this form with next communication to applicant.
`1Applicant's unique citation designation number (optional). 2Applicant is to place a check mark here if English language Translation is attached.
`This collection of information is required by CFR 1 .98. The information is required to obtain or retain a benefit by the public which is to file (and by the
`US PTO to process) an application. Confidentiality is governed by 35 U.S.C. 122 and 37 CFR 1.14. This collection is estimated to take 2 hours to
`complete, including gathering, preparing, and submitting the completed application form to the USPTO. Time will vary depending upon the individual case.
`Any comments on the amount of time you require to complete this form and/or suggestions for reducing this burden, should be sent to the Chief
`Information Officer, U.S. Patent and Trademark Office, P.O. Box 1450, Alexandria, VA 22313-1450. DO NOT SEND FEES OR COMPLETED FORMS TO
`THIS ADDRESS. SEND TO: Commissioner for Patents, P.O. Box 1450, Alexandria, VA 22313-1450.
`If you need assistance in completing the form, call 1-800-PTO-9199 (1-800-786-9199) and select option 2.
`
`33.
`
`34.
`
`ALL REFERENCES CONSIDERED EXCEPT WHERE LINED THROUGH. /C.V./
`
`LUMENIS EX1057
`Page 2
`
`

`

`PTO/Sb/08b (06-09)
`Approved for use through 07/31/2009. 0MB 0651-0031
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid
`0MB control number.
`
`Complete if Known
`Aoolication Number
`13/024,727
`February 10, 2011
`Filinq Date
`Simon
`First Named Inventor
`Art Unit
`tbd
`Examiner Name
`tbd
`Attorney Docket Number
`ELEC-34
`
`Substitute for form 1449/PTO
`
`INFORMATION DISCLOSURE
`STATEMENT BY APPLICANT
`
`(Use as many sheets as necessary)
`I 3
`I OF
`I 7
`Sheet
`
`Exami Cite No.
`ner
`lnts
`
`35.
`
`36.
`
`37.
`38.
`
`39.
`
`40.
`41.
`42.
`
`43.
`
`44.
`
`45.
`
`46.
`
`47.
`
`48.
`
`49.
`
`50.
`
`51.
`
`52.
`
`Include name of the author (in CAPITAL LETTERS), title of the article (when
`appropriate), title of the item (book, magazine, journal, serial, symposium, catalog,
`etc.), date, pages, volume/issue number(s), publisher, city and/or country where
`published.
`Arbor Ml).
`FEYNMAN et al. The Feynman Lectures on Physics. Volume II. Addison-Wesley Publ. Co.
`(Reading MA, 1964), page 15-15.
`FIBIGER et al. Reward, motivation, cognition: psychobiology of esotelencephalic
`dopamine systems. In: Mountcastle VB, Bloom FE, Geyer SR, eds. Handbook of
`physiology: the nervous system IV. Bethesda, MD: American Physiological Society,
`1986:647-675.
`FINGERS. A happy state of mind. Archives of Neurology 1998; 55:241-250.
`FISHMAN et al. Construct Validity and Frequency of Euphoria Sclerotica in Multiple
`Sclerosis. The Journal of Neuropsychiatry and Clinical Neurosciences 16 (2004): 350-356.
`FOLLESA P et al. Vagus nerve stimulation increases norepinephrine concentration and the
`gene expression of BON F and bFG F in the rat brain. Brain Research 1179(2007): 28-34.
`FRIED et al. Electric current stimulates laughter. Nature 391 (1998): 650.
`FROEHLICH. Opioid peptides. Alcohol health and research world. 132-136.
`FUCHS. The Production of Pleasure by Stimulation of the Brain: An Alleged Conflict
`Between Science and Philosophy. Philosophy and Phenomenological Research, 36 (4,
`1976): 494-505.
`GEORGE et al. Mechanisms of action of vagus nerve stimulation (VNS). Clinical
`Neuroscience Research 4 (2004) 71-79.
`GEORGE et al. Noninvasive techniques for probing neurocircuitry and treating illness:
`vagus nerve stimulation (VNS), transcranial magnetic stimulation (TMS) and transcranial
`direct current stimulation (tDCS). Neuropsychopharmacoloav Reviews (2010) 35, 301-316.
`GRANT et al. Multicenter Investigation of the Opioid Antagonist Nalmefene in the
`Treatment of Pathological Gambling. Am J Psychiatry 163(2006) :303-312.
`GREEN et al. Conducting polymer-hydrogels for medical electrode applications. Sci.
`Technol. Adv. Mater. 11 (2010) 014107 (13pp).
`GRIFFIN. Perispinal etanercept: Potential as an Alzheimer therapeutic. Journal of
`Neuroinflammation 2008, 5:3.
`GROVES et al. Vagal nerve stimulation: a review of its applications and potential
`mechanisms that mediate its clinical effects. Neurosci Biobehav Rev (2005) 29:493-500.
`HAERTZEN et al. Addiction Research Center Inventory (ARCI): Measurement of euphoria
`and other drug effects. In M.A. Bozarth (Ed.), Methods of assessing the reinforcing
`properties of abused druas (pp_ 489-524). New York: Sprinaer-Verlaa.
`HAKKINEN et al. Which structures are sensitive to painful transcranial stimulation?
`Electromyogr. clin. Neurophysiol. 1995, 35:377-383.
`HAM DY et al. Long-term reorganization of human motor cortex driven by short-term
`sensory stimulation. Nature Neuroscience 1 (issue 1, May 1998) :64-68.
`HAMILTON. A Rating Scale for Depression. Journal of Neurology, Neurosurgery, and
`Psychiatry. 23(1960) :56-62.
`
`Date
`Examiner
`08/12/2013
`iCatherine Voorhees/
`Considered
`Si nature
`*EXAMINER: Initial if reference considered, whether or not citation is in conformance with MPEP 609. Draw line through citation if not in conformance and
`not considered. Include copy of this form with next communication to applicant.
`1Applicant's unique citation designation number (optional). 2Applicant is to place a check mark here if English language Translation is attached.
`This collection of information is required by CFR 1 .98. The information is required to obtain or retain a benefit by the public which is to file (and by the
`US PTO to process) an application. Confidentiality is governed by 35 U.S.C. 122 and 37 CFR 1.14. This collection is estimated to take 2 hours to
`complete, including gathering, preparing, and submitting the completed application form to the USPTO. Time will vary depending upon the individual case.
`Any comments on the amount of time you require to complete this form and/or suggestions for reducing this burden, should be sent to the Chief
`Information Officer, U.S. Patent and Trademark Office, P.O. Box 1450, Alexandria, VA 22313-1450. DO NOT SEND FEES OR COMPLETED FORMS TO
`THIS ADDRESS. SEND TO: Commissioner for Patents, P.O. Box 1450, Alexandria, VA 22313-1450.
`
`ALL REFERENCES C(ryNfSf D1:!'f!ff!CT~,tC'c~W-~~~e9t!r~tfTfU!r-'fO't1~fF IC. V ./
`
`LUMENIS EX1057
`Page 3
`
`

`

`PTO/Sb/08b (06-09)
`Approved for use through 07/31/2009. 0MB 0651-0031
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid
`0MB control number.
`
`Complete if Known
`Aoolication Number
`13/024,727
`February 10, 2011
`Filinq Date
`Simon
`First Named Inventor
`Art Unit
`tbd
`Examiner Name
`tbd
`Attorney Docket Number
`ELEC-34
`
`Substitute for form 1449/PTO
`
`INFORMATION DISCLOSURE
`STATEMENT BY APPLICANT
`
`(Use as many sheets as necessary)
`I 4
`I OF
`I 7
`Sheet
`
`Exami Cite No.
`ner
`lnts
`
`53.
`
`54.
`
`55.
`
`56.
`
`57.
`58.
`
`59.
`
`60.
`
`61.
`
`62.
`
`63.
`
`64.
`
`65.
`
`66.
`
`67.
`
`68.
`
`69.
`70.
`
`71.
`
`72.
`
`Include name of the author (in CAPITAL LETTERS), title of the article (when
`appropriate), title of the item (book, magazine, journal, serial, symposium, catalog,
`etc.), date, pages, volume/issue number(s), publisher, city and/or country where
`published.
`HEIMBURG et al. On soliton propagation in biomembranes and nerves. PNAS vol. 102
`(no. 28, July 12, 2005): 9790-9795.
`HENNENLOTTER et al. The Link between Facial Feedback and Neural Activity within
`Central Circuitries of Emotion-New Insights from Botulinum Toxin--lnduced Denervation
`of Frown Muscles. Cerebral Cortex 19(2009) :537-542
`HENRY. Therapeutic mechanisms of vagus nerve stimulation. Neurology 59(6,2002): S3-
`S14.
`HOLSTEGE et al. Brain Activation during Human Male Ejaculation. The Journal of
`Neuroscience 23(27,2003):9185-9193.
`HORGAN. The forqotten era of brain chips. Scientific American 293(4,2005):66-73.
`HOUSE, et al. Mood disorders after stroke and their relation to lesion location. A CT scan
`study. Brain 113(4, 1990) :1113-1129.
`HOVEY et al. The Guide to Magnetic Stimulation, The Magstim Company Ltd, Spring
`Gardens, Whitland, Carmarthenshire, SA34 OHR, United Kinqdom, 2006.
`HSU et al. Analysis of efficiency of magnetic stimulation. IEEE Trans Biomed Eng. 2003
`Nov; 50 (11):1276-85.
`JEAN A. The nucleus tractus solitarius: neuroanatomic, neurochemical and functional
`aspects. Arch Int Physiol Biochim Biophys 1991 ;99(5):A3-A52.
`KENNEDY et al. Dysregulation of Endogenous Opioid Emotion Regulation Circuitry in
`Major Depression in Women. Arch Gen Psychiatry. 2006;63:1199-1208.
`KHEDR et al. Aref Electrophysiological study of vocal-fold mobility disorders using a
`maqnetic stimulator. European Journal of Neuroloqy 2002, 9: 259-267.
`KHEDR et al. Dysphagia and hemispheric stroke: A transcranial magnetic study.
`Neurophysiologie Clinique/Clinical Neurophysiology (2008) 38, 235-242).
`KJELSAS et al. Antecendent and consequences of binge eating episodes in women with
`an eatinq disorder. EatWeiqht Disord. 9 (1, 2004):7-15.
`KLEIN et al. A case report of hypomania following vagus nerve stimulation for refractory
`epilepsy .J Clin Psychiatry. 2003 Apr;64(4):485.
`KLEMENC-KETIS et al. The effect of carbon dioxide on near-death experiences in out-of-
`hospital cardiac arrest survivors: a prospective observational study. Critical Care 2010,
`14:R56.
`KONERU et al. Endogenous Opioids: Their Physiological Role and Receptors. Global
`Journal of Pharmacoloqy, 3 (3,2009): 149-153.
`KOOB et al. Neuroscience of Addiction. Neuron, Vol. 21 (2008), 467-476.
`KOUTROUMANIDIS. Euphoric (hedonic) theta hypersynchrony in early childhood.
`Epileptic Disord 2006; 8 (4): 299-304.
`KRACK et al. Mirthful Laughter Induced by Subthalamic Nucleus Stimulation. Movement
`Disorders 16 (5, 2001): 867-8751.
`LEMERRER et al. Reward Processinq by the Opioid System in the Brain. Physiol Rev
`
`/Catherine Voorr1ees/
`
`Date
`Examiner
`08i12/2013
`Considered
`Si nature
`*EXAMINER: Initial if reference considered, whether or not citation is in conformance with MPEP 609. Draw line through citation if not in conformance and
`not considered. Include copy of this form with next communication to applicant.
`1Applicant's unique citation designation number (optional). 2Applicant is to place a check mark here if English language Translation is attached.
`This collection of information is required by CFR 1 .98. The information is required to obtain or retain a benefit by the public which is to file (and by the
`US PTO to process) an application. Confidentiality is governed by 35 U.S.C. 122 and 37 CFR 1.14. This collection is estimated to take 2 hours to
`complete, including gathering, preparing, and submitting the completed application form to the USPTO. Time will vary depending upon the individual case.
`Any comments on the amount of time you require to complete this form and/or suggestions for reducing this burden, should be sent to the Chief
`Information Officer, U.S. Patent and Trademark Office, P.O. Box 1450, Alexandria, VA 22313-1450. DO NOT SEND FEES OR COMPLETED FORMS TO
`THIS ADDRESS. SEND TO: Commissioner for Patents, P.O. Box 1450, Alexandria, VA 22313-1450.
`If you need assistance in completing the form, call 1-800-PTO-9199 (1-800-786-9199) and select option 2.
`
`ALL REFERENCES CONSIDERED EXCEPT WHERE LINED THROUGH. /C.V./
`
`LUMENIS EX1057
`Page 4
`
`

`

`PTO/Sb/08b (06-09)
`Approved for use through 07/31/2009. 0MB 0651-0031
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid
`0MB control number.
`
`Complete if Known
`Aoolication Number
`13/024,727
`February 10, 2011
`Filinq Date
`Simon
`First Named Inventor
`Art Unit
`tbd
`Examiner Name
`tbd
`Attorney Docket Number
`ELEC-34
`
`Substitute for form 1449/PTO
`
`INFORMATION DISCLOSURE
`STATEMENT BY APPLICANT
`
`(Use as many sheets as necessary)
`I 5
`I OF
`I 7
`Sheet
`
`Exami Cite No.
`ner
`lnts
`
`73.
`
`74.
`
`75.
`76.
`
`77.
`
`78.
`
`79.
`
`80.
`
`81.
`
`82.
`
`83.
`
`84.
`
`85.
`
`86.
`87.
`88.
`
`89.
`
`90.
`
`Include name of the author (in CAPITAL LETTERS), title of the article (when
`appropriate), title of the item (book, magazine, journal, serial, symposium, catalog,
`etc.), date, pages, volume/issue number(s), publisher, city and/or country where
`published.
`89(2009): 1379-1412.
`LIBOFF. Signal shapes in electromagnetic therapies: a primer. pp. 17-37 in:
`Bioelectromagnetic Medicine (Paul J. Rosch and Marko S. Markov, eds.). New York:
`Marcel Dekker (2004).
`LIU et al. On the Induced Electric Field Gradients in the Human Body for Magnetic
`Stimulation by Gradient Coils in MRI, IEEE Transactions on Biomedical Engineering 50:
`(No. 7, July 2003) pp. 804-815.
`MA. Neurobioloay of Acupuncture: Toward CAM. eCAM 2004;1 (1 )41-47.
`MAN et al. Magnetic stimulation for the measurement of respiratory and skeletal muscle
`function. Eur Respir J 2004; 24: 846-860.
`MANJI et al. Enhancing Neuronal Plasticity and Cellular Resilience to Develop Novel,
`Improved Therapeutics for Difficult-to-Treat Depression. Biol Psychiatry 53 (2003):707-
`742.
`MASAND et al. Use of stimulants in the medically ill. Psychiatric Clinics of North America
`19(3, 1996): 515-547.
`MASON et al. A Double-blind, Placebo-Controlled Study of Oral Nalmefene for Alcohol
`Dependence. Arch Gen Psychiatry 56(1999) :719-724.
`McAULIFFE et al. A Test of Lindesmith's Theory of Addiction: The Frequency of Euphoria
`Among Long-Term Addicts. The American Journal of Sociology 79 (4, 1974): 795-840. See
`00. 800-803
`MEGA et al. The limbic system: an anatomic, phylogenetic, and clinical perspective.
`Journal of Neuropsychiatry and Clinical Neurosciences 9 (1997) :315-330.
`MELVILLE. Bolus Dose of Ketamine Offers Fast-Acting Alleviation of Acute Depression in
`ED Settina. Medscape Medical News (2010): Article 729622.
`MONCRIEFF et al. Active placebos versus antidepressants for depression. Cochrane
`Database of Systematic Reviews 2004, Issue 1. Art. No.: CD003012.
`MONTGOMERY et al. A new depression scale designed to be sensitive to change. Br J
`Psychiatry 134(1979) :382-389.
`NEMEROFF et al. VNS Therapy in Treatment-Resistant Depression: Clinical Evidence and
`Putative Neurobioloaical Mechanisms. Neuropsychopharmacoloay (2006) 31, 1345-1355.
`NESTLER et al. Neurobioloav of Depression. Neuron 34(2002), 13-25.
`NICOLL et al. The Brain's Own Marijuana. Sci Am. 291(6,2004):68-75.
`NILSSON et al. Determining the site of stimulation during magnetic stimulation of the
`peripheral nerve, Electroencephalographs and clinical neurophysiology. vol 85, pp. 253-
`264, 1992.
`NUTT et al. Development of a rational scale to assess the harm of drugs of potential
`misuse. Lancet 369 (2007): 1047-1053.
`OKUN et al. What's in a "Smile?" Intra-operative Observations of Contralateral Smiles
`Induced by Deep Brain Stimulation. Neurocase, 10(4): 271-279, 2004.
`
`Date
`Examiner
`/Catherine Voorhees/
`08/12/2013
`Considered
`Si nature
`*EXAMINER: Initial if reference considered, whether or not citation is in conformance with MPEP 609. Draw line through citation if not in conformance and
`not considered. Include copy of this form with next communication to applicant.
`1Applicant's unique citation designation number (optional). 2Applicant is to place a check mark here if English language Translation is attached.
`This collection of information is required by CFR 1 .98. The information is required to obtain or retain a benefit by the public which is to file (and by the
`US PTO to process) an application. Confidentiality is governed by 35 U.S.C. 122 and 37 CFR 1.14. This collection is estimated to take 2 hours to
`complete, including gathering, preparing, and submitting the completed application form to the USPTO. Time will vary depending upon the individual case.
`Any comments on the amount of time you require to complete this form and/or suggestions for reducing this burden, should be sent to the Chief
`Information Officer, U.S. Patent and Trademark Office, P.O. Box 1450, Alexandria, VA 22313-1450. DO NOT SEND FEES OR COMPLETED FORMS TO
`THIS ADDRESS. SEND TO: Commissioner for Patents, P.O. Box 1450, Alexandria, VA 22313-1450.
`If you need assistance in completing the form, call 1-800-PTO-9199 (1-800-786-9199) and select option 2.
`
`ALL REFERENCES CONSIDERED EXCEPT WHERE LINED THROUGH. /C.V./
`
`LUMENIS EX1057
`Page 5
`
`

`

`PTO/Sb/08b (06-09)
`Approved for use through 07/31/2009. 0MB 0651-0031
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid
`0MB control number.
`
`Complete if Known
`Aoolication Number
`13/024,727
`Filinq Date
`February 10, 2011
`Simon
`First Named Inventor
`Art Unit
`tbd
`Examiner Name
`tbd
`Attorney Docket Number
`ELEC-34
`
`Substitute for form 1449/PTO
`
`INFORMATION DISCLOSURE
`STATEMENT BY APPLICANT
`
`(Use as many sheets as necessary)
`I 6
`I OF
`I 7
`Sheet
`
`Exami Cite No.
`ner
`lnts
`
`91.
`
`92.
`
`93.
`94.
`
`95.
`
`96.
`
`97.
`
`98.
`
`99.
`
`100.
`
`101.
`
`102.
`
`103.
`
`104.
`
`105.
`
`106.
`
`107.
`
`108.
`
`109.
`
`Include name of the author (in CAPITAL LETTERS), title of the article (when
`appropriate), title of the item (book, magazine, journal, serial, symposium, catalog,
`etc.), date, pages, volume/issue number(s), publisher, city and/or country where
`published.
`OLNEY et al. A comparison of magnetic and electric stimulation of peripheral nerves.
`Muscle Nerve 1990:13:957-963.
`PACH ER et al.The Endocannabinoid System as an Emerging Target of Pharmacotherapy.
`PharmacoloQical Reviews September 2006 vol. 58 no. 3 389-462.
`PECINA et al.Hedonic Hot Spots in the Brain. Neuroscientist 12(6,2006):500-511.
`POLAK T. et al. Far field potentials from brain stem after transcutaneous vagus nerve
`stimulation: optimization of stimulation and recording parameters. J Neural Transm. 2009
`Oct; 116(10):1237-42.
`PRICE et al. Neurocircuitry of Mood Disorders. Neuropsychopharmacology Reviews
`35(2010), 192-216.
`RADA et al. Opioids in the hypothalamus control dopamine and acetylcholine levels in the
`nucleus accumbens. Brain Research 1312(2010) 1-9.
`RAFFERTY et al. Magnetic phrenic nerve stimulation to assess diaphragm function in
`children followinQ liver transplantation. Pediatr Grit Care Med 2001, 2:122-126.
`RAINFORTH et al. Stress Reduction Programs in Patients with Elevated Blood Pressure: A
`Systematic Review and Meta-analysis. Curr Hypertens Rep. 9(6,2007):520-528].
`RATTAY. The basic mechanism for the electrical stimulation of the nervous system.
`Neuroscience Vol. 89, No. 2, pp. 335-346, 1999.
`RESSLER et al. Role of serotonergic and noradrenergic systems in the pathophysiology of
`depression and anxiety disorders. Depression and Anxiety 12 (Supplement 1, 2000) :2-19.
`RICHARDSON. Hypomania: A brief review of conceptual and diagnostic issues. The New
`Zealand Medical Student Journal Number 1 O (2009): 25-28.
`SAVER et al. The neural substrates of religious experience. The Journal of
`Neuropsychiatry and Clinical Neurosciences 9 (1997) :498-510.
`SAWICKI et al. Mathematical Modelling of Vagus Nerve Stimulation. pp. 92-97 in:
`Krawczyk, A. Electromagnetic Field, Health and Environment: Proceedings of EHE'07.
`Amsterdam, IOS Press, 2008.
`SAYETTE. Does drinking reduce stress? Alcohol Research and Health 23 (4,1999):250-
`255.
`SCHACHTER. Vagus nerve stimulation: mood and cognitive effects. Epilepsy & Behavior 5
`(2004) S56-S59.
`SCHLAEPFER et al. Site of Opioid Action in the Human Brain: Mu and Kappa Agonists'
`Subjective and Cerebral Blood Flow Effects. Am J Psychiatry 155(1998) :470-473.
`SHAFIK, A. Functional magnetic stimulation of the vagus nerve enhances colonic transit
`time in healthy volunteers. Tech Coloproctol (1999) 3:123-12.
`SHAH et al. Selective Serotonin Reuptake Inhibitors for Premenstrual Syndrome and
`Premenstrual Dysphoric Disorder: A Meta-Analysis. Obstet Gynecol. 111 (5,2008): 1175-
`1182.
`SIMILOWSKI, T. et al. Cervical maQnetic stimulation: a new painless method for bilateral
`
`Date
`Examiner
`08i12/2013
`/Catherine Voorhees/
`Considered
`Si nature
`*EXAMINER: Initial if reference considered, whether or not citation is in conformance with MPEP 609. Draw line through citation if not in conformance and
`not considered. Include copy of this form with next communication to applicant.
`1Applicant's unique citation designation number (optional). 2Applicant is to place a check mark here if English language Translation is attached.
`This collection of information is required by CFR 1 .98. The information is required to obtain or retain a benefit by the public which is to file (and by the
`US PTO to process) an application. Confidentiality is governed by 35 U.S.C. 122 and 37 CFR 1.14. This collection is estimated to take 2 hours to
`complete, including gathering, preparing, and submitting the completed application form to the USPTO. Time will vary depending upon the individual case.
`Any comments on the amount of time you require to complete this form and/or suggestions for reducing this burden, should be sent to the Chief
`Information Officer, U.S. Patent and Trademark Office, P.O. Box 1450, Alexandria, VA 22313-1450. DO NOT SEND FEES OR COMPLETED FORMS TO
`THIS ADDRESS. SEND TO: Commissioner for Patents, P.O. Box 1450, Alexandria, VA 22313-1450.
`
`ALL REFERENCES C(ryNfSf D1:!'f!ff!CT~,tC'c~W-~~~e9t!r~tfTfU!r-'fO't1~fF IC. V ./
`
`LUMENIS EX1057
`Page 6
`
`

`

`PTO/Sb/08b (06-09)
`Approved for use through 07/31/2009. 0MB 0651-0031
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid
`0MB control number.
`
`Complete if Known
`Aoolication Number
`13/024,727
`February 10, 2011
`Filinq Date
`Simon
`First Named Inventor
`tbd
`Art Unit
`Examiner Name
`tbd
`Attorney Docket Number
`ELEC-34
`
`Substitute for form 1449/PTO
`
`INFORMATION DISCLOSURE
`STATEMENT BY APPLICANT
`
`(Use as many sheets as necessary)
`I 7
`I OF
`I 7
`Sheet
`
`Exami Cite No.
`ner
`lnts
`
`Include name of the author (in CAPITAL LETTERS), title of the article (when
`appropriate), title of the item (book, magazine, journal, serial, symposium, catalog,
`etc.), date, pages, volume/issue number(s), publisher, city and/or country where
`published.
`phrenic nerve stimulation in conscious humans. J. Aool. Phvsiol. 67(4): 1311-1318, 1989.
`110. SIMS et al. Assessing the clinical utility of the magnetic stimulator for measuring response
`latencies in the laryngeal muscles. Otolaryngol Head Neck Sura 1996; 114:761-7.
`111 . SKOLNICK et al. Current perspectives on the development of non-biogenic amine-based
`antidepressants. Pharmacoloaical Research 43(5,2001 ):411-422.
`112. STARKSTEIN, Sergio E and Robinson, Robert G. Mechanism of Disinhibition After Brain
`Lesions. The Journal of Nervous & Mental Disease 185(2, 1997): 108-114.
`113. SU IH KO. Modelling the response of scalp sensory receptors to transcranial electrical
`stimulation. Med. Biol. Ena. Comput., 2002, 40, 395-401
`114. TERRY. Vagus nerve stimulation: a proven therapy for treatment of epilepsy strives to
`improve efficacy and expand applications. Cont Proc IEEE Eng Med Biol Soc.
`2009;2009:4631-4.
`115. VORUGANTI et al. Brain imaging research on subjective responses to psychotropic drugs.
`Acta Psychiatr Scand 2005: 111 (Suppl. 427): 22-281.
`116. WALSH et al. VNS and depression: current status and future directions. Expert Rev.
`Medical Devices 1 (1,2004) :155-160.
`117. WANG et al. A three-dimensional finite element method for computing